News, Conferences and Congresses
June 27, 2014: Reig Jofre ready to ateend CPhI Worldwide in Paris, France
ICSE Area / Hall 2 / Stand 2A27
June 26, 2014: Natraceutical and Reig Jofre agree to marge
Information fusion protocol.
Download the document (.PDF)
June 20, 2014: GynEC®-DX, the first biotechnological diagnostic test developed in Spain for the early detection or endometrial cancer, arrives in Sweden, Norway, and Denmark
GynE®C-DX, the first biotechnological diagnostic test entirely developed in Spain for the early detection of endometrial cancer, is now available on the Scandinavian market, more specifically, in Sweden, Norway, and Denmark.
March 26, 2014: Reig Jofre donates medicines to the Philippines
Reig Jofre is donating essential medicines to the Philippines in an effort to help mitigate the disasters of the recent flooding
February 13, 2014: Ignasi Biosca Reig, new chairman of CataloniaBIO
Ignasi Biosca has been appointed as the new Chairman of CataloniaBIO, the Catalan Association of Biotechnology Companies, in the elections that took place last January.
December 11, 2013: Reig Jofre will produce and market injectable drugs manufactured in Toledo for the United States
The Group obtains FDA approval for its plant in Toledo
October 21, 2013:  Reig Jofre at CPhI Worldwide 2013 in Frankfurt
October 24, 2013: The Sala Laboratory the 58 th National Congress of the Spanish Society of Pharmacology in Hospitals
Palacio de Congresos y Ferias, Málaga, 22 to 25 October 2013
February 25, 2013: Reig Jofre is sponsoring the BIO-Europe Spring 2013 partnering congress
January 8, 2013: Reig Jofre joins generics manufacturer Mylan to enter US market
This Catalan pharmaceutical group expects to start selling its products in this market in late 2014. They currently export 55% of their drugs.
July 31, 2012: RJ Biotech Services at Biospain - Bilbao (Spain)
July 30, 2012: RJ at Visiongain - 6th Lyophilisation - London, UK
July 6, 2012: RJ Biotech Services participated in the BIO International Convention 2012 in Boston
January 31, 2012: 2012 GPhA Annual Meeting and Business Exposition
JW Marriott Orlando Grande Lakes. Orlando, Florida
Reig Jofre Group will participate at the next GPhA Annual Meeting 2012 (February 22 - 24) that will take place at the JW Marriott Orlando Grande Lakes (Orlando, FL). 
GPhA offers networking opportunities and professional business environment connected with the generic industry.
October 20, 2011: CPhI Worldwide 2011. Messe Frankfurt, Germany
Reig Jofre Group exhibit at ICSE (CPhI) in Frankfurt 25 to 27 October, 2011
Visit us at Stand 41D40

RJ Speaker:
  • "Transfer & Scale Up for a Freeze Dried in CMO" - Patricia Rodríguez - Transfer Technology  Manager RJ Barcelona.
October 13, 2011: 2011 PDA Europe Pharmaceutical Freeze Drying Technology
25 - 28 October 2011 - Hotel Icaria Barcelona. Barcelona - Spain

September 15, 2011: Oryzon announces the commercialization of its first genetic test in collaboration with Reig Jofre
Oryzon's first own product on the market will be GynEC-Dx, a new system for the early detection of cervical cancer, jointly developed with Laboratorio Reig Jofre and for which marking authorization is scheduled for January 2012.

August 29, 2011: Reig Jofre at Contract Pharma 2011 - 10th Annual Contracting & Outsourcing Conference & Tabletop Exhibition
Hyatt Regency New Brunswick, NJ
Reig Jofre Group will be attending the next Contract Pharma 2011 (22rd and 23th of September) that will take place at the Hyatt Regency Hotel in New Brunswick (New Jersey)
July 29, 2011: Reig Jofre at VISIONGAIN - 5 th Lyophilisation
Conference Centre, London, UK
"Optimising technologies & techniques for stability, delivery and longevity of pharmaceuticals and biologics"
Reig Jofre will be attending the next Visiongain ( 7 - 9 September ) that will take place at the Visiongain Conference Centre in London
June 9, 2011: Reig Jofre at BIO Washington 2011, Walter E. Washington Convention Center (United States)
The world's most important convention for the biotechnology sector takes place this year in the capital of USA, Washington DC, from 27-30 June. Washington DC, one of the major life sciences hub, has grown considerably over the past few years. Reig Jofre participates as an exhibitor: Booth 3237-12.
May 23, 2011: Reig Jofre, Ediciones Mayo 2011 Award for the Best International Career
May 2, 2011: Reig Jofre creates a biotechnology services company
The laboratory started the process to commercialize its first product in U.S. and allies with the swedish medical technology firm Nares.
April 27, 2011: Reig Jofre continues its commitment to biotechnology
March 26, 2011: Reig Jofre focuses its R&D toward the biotechnological sector
January 26, 2011: Article published "Molecular markers of endometrial carcinoma detected in uterine aspirates"
January 18, 2011: Reig Jofre, Fabricantes farmacéuticos con vocación biotecnológica
News article published in the supplement to El Periódico de Catalunya: Biotecnología
January 3, 2011: "Cáncer, vacunas y biotecnología, alternativas para Reig Jofre"
News article published in Diario Médico
December 2, 2010: RJ Biotech Services en el Fòrum Biocat 2010. Casa Llotja de Mar. Barcelona

November 29, 2010: PDA 2010 Pharmaceutical Feeze Drying Workshop. Current Science and Technology of Lyophilization. November 17 - 18, 2010. Sheraton San Diego Hotel and Marina - San Diego

November 25, 2010: Reig Jofre focuses on the U.S.
The pharmaceutical company Reig Jofre has achieved a business milestone this year: it has reached 100 million Euros in sales. For next year, it is preparing another one: to enter the U.S. market, the top market in the world for the pharmaceutical industry. The company, based in Sant Joan Despí - Barcelona, has acquired a contract to manufacture antibiotics for the U.S. and is working to present the registration dossier in January to get FDA approval.
November 25, 2010: Guaranteeing a Quality Scale-up
Enric Jo at Reig Jofre Group provides a detailed account of a first approach for applying
quality by design in a scale-up of a lyophilisation cycle for an antiviral product
October 19 - 22, 2010: Laboratorio SALA en el 55 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria. Madrid

October 16, 2010: Grupo Reig Jofre celebra el décimo aniversario de su centro de producción de Toledo
Es una de las plantas más avanzadas de Europa dedicada a la fabricación de antibióticos como penicilinas y cefalosporinas.

El centro de producción del Grupo farmacéutico Reig Jofre en Toledo celebra estos días su décimo aniversario. En estos años, se ha consolidado como una de las más avanzadas de Europa por su alta tecnología, calidad productiva y capacidad de fabricación, ya que cada año produce más de 40 millones de dosis de antibióticos con penicilina y cefalosporina.

October 5-7, 2010: CPhI Worldwide 2010. París Nord Villepinte. Francia
Reig Jofre Group interviene en la CPhI 2010, que se celebra los días 5, 6 y 7 de Octubre de 2010 en París Nord Villepinte (Francia).
Localización en la Exposición Comercial: Área ICSE - Stand 4F86
September 28, 2010: Laboratorio Orravan, Reig Jofre Group, launches Amnioplus H2O water paste
Laboratorio Orravan, Reig Jofre Group, reinforces its OTC - Consumer HealthCare product portfolio with Amnioplus H2O water paste.
Amnioplus H2O water paste is a specially-formulated product to prevent, alleviate and treat diaper dermatitis.
September 27, 2010: Laboratorio Orravan, Reig Jofre Group, ha celebrado las Jornadas Formativas de Ciclo a nivel nacional con su Red Comercial en las que ha presentado su nuevo producto
Durante la segunda quincena de Septiembre Laboratorio Orravan, Reig Jofre Group, ha celebrado las Jornadas Formativas de Ciclo con su Red Comercial, en las que ha presentado su nuevo producto Amnioplus H2O pasta al agua.
September 23 - 24, 2010: The 9 th Annual Contract Pharma 2010. Hyatt Regency, New Brunswick, NJ
Reig Jofre Group will be attending the next Contract Pharma 2010 (23rd and 24th of September) that will take place at the Hyatt Regency Hotel in New Brunswick (New Jersey)
June 10, 2010: Oryzon y Reig Jofre muestran sus avances en la detección precoz de cáncer de útero en el congreso científico de la American Society of Clinical Oncology (ASCO) en Chicago
Ambas compañías desarrollan esta colaboración desde 2007.
Con ello se convierten en una de las pocas empresas de biotecnología que pueden comercializar sus propios productos.
April 20, 2010: Se celebra la primera Jornada Técnica del Consorcio ONCOLOGICA
April 20 - 22, 2010: RJ at INTERPHEX 2010, Jacob K. Javits Convention Center. New York
Comercial exhibition, Level 3, satnd 110

March 15, 2010: Interview with Emilia Castellano, Product Manager Dermatology - RJ Group

March 1, 2010: Thermal fingerprinting: a way to optimise lyophilization

 

February 24-26, 2010: RJ at VISIONGAIN, 3rd Annual Lyophilization

Ensuring optimum formulations for pharmaceuticals and biologicals

Boston Harbor Hotel at Rowes Wharf, Boston, USA.

Main manufacturing challenges in lyophilisation processes
• Main failures with lyophilised production: the real world.
• Integration of quality challenges into cost challenges.
• From basic product knowledge to product release.

RJ speaker: Enric Jo, PhD
October 20 - 22, 2009: 22nd A3P International Congress. Biarritz
"Procédé de Lyophilisation: Succès dans le Scale-up".
RJ speaker: Enric Jo, PhD
October 13 - 15,  2009: Reig Jofre at CPhI Worldwide - Madrid
September 29 - 30, 2009: PDA Europe, Pharmaceutical Freeze Drying Technology. Frankfurt.
Is There a Future of Freeze Dried Products?
"Technologies Topics: Machines and Equipment; IPCs and Test Methods; Container, Components and Devices; Handling of Freeze Dried Products".
RJ coordinator: Enric Jo, PhD
September 15 -17,  2009: VISIONGAIN, 2nd Annual Lyophilisation in London, at BSG Conference center.
  • "Main Manufacturing Challenges in a Lyophilization Processes".
    RJ speaker: Nerea García
  • Panel Discussion: State of art in Lyophilization Technology.
    RJ coordinator: Enric Jo, PhD
July 14, 2009: Grupo Reig Jofre da el salto internacional a través de la compra de Bioglan AB, laboratorio farmacéutico en Suecia, especializado en el área dermatológica, por un importe de € 7MM.  
Reig Jofre da un fuerte impulso a su vocación internacional al haber comprado el laboratorio farmacéutico sueco Bioglan AB, especializado en el área dermatológica y las licencias de comercialización de nueve especialidades farmacéuticas de Bioglan Pharma AB, actualmente comercializadas en Suecia. Noruega, Dinamarca e Islandia. El importe de la operación ha ascendido a € 7MM y permitirá al Grupo RJ contar con un equipo de I+D e  instalaciones productivas propias en el extranjero, así como una cartera de productos propios en los mercados escandinavos. La operación ha sido financiada con recursos propios y a través de deuda de las principales entidades financieras con las que el Grupo RJ tiene relación.
June 17 - 20,  2009 : 37th National Dermatology and Veneorology Congress.
Madrid. Laboratorios MEDEA, Commercial exhibition. Stand No. 10
April 16,  2009 : IMA-Edwards, in Barcelona.
  • "General Insight on Issues Related with Freeze Drying Processes in Industrial Manufacturing".
    RJ speaker: Enric Jo, PhD
April 2, 2009 : PDA Europe, Interest Group Meeting: Freeze Drying, in Frankfurt Sheraton Offenbach Hotel. Am Büsing Palais I Berliner Str.111- 63065 Offenbach
  • "Determination of the sublimation rate for the optimisation of primary drying".   RJ speaker: Laura Noguera
  • "Proposals to define a working structure in the European Interest Group of Freeze Drying".
    RJ speaker: Enric Jo, PhD
December 3 - 4, 2008: ISPE Conference. Lyophilisation: Scientific Issues of the Process an Introduction to Risk-based Approach, in Barcelona, Spain
  • "Successful scale up from R&D to Production (Case Study)".
    RJ speaker: Enric Jo, PhD
23-24 September 2008: PDA Europe, Pharmaceutical Freeze Drying Technology, in Brussels, Belgium.
  • "Parameters Characterization of a lyophilisation Cycle".
    RJ speaker: Enric Jo, PhD
November 21,  2007: Reig Jofre Group invests € 6 million in a new freeze-drying unit for sterile products for injection and to extend the liquids area in the Sant Joan Despí plant.
3 years after the extension of the freeze-drying unit, RJ invests in a new plant, which will increase its current production capacity by a factor of three. The investment has been financed with own funds and funds from outside sources, with the support of the Institut Català de Finances (ICF).
18 June 2007: The Reig Jofre Group reacquisition 40% of Sodicaman’s shares in RJ Cefas
5 years after the creation of the company, a plant is consolidated internationally, employing more than 25 people, with a production of 7 million units a year.
February 23, 2007: Reig Jofre and Oryzon Genomics join together to work on research for cancer diagnosis
The pharmaceutical groups Reig Jofre and Oryzon Genomics announce an agreement for the development of early diagnosis and prognosis of endometrial cancer.
  Back to news RJ
We use own and third-party "cookies" to improve our services and for statistical information of user navigation. If you continue browsing, consider that you accept its use. You can extend this information here.